254 related articles for article (PubMed ID: 23892183)
1. Models for open innovation in the pharmaceutical industry.
Schuhmacher A; Germann PG; Trill H; Gassmann O
Drug Discov Today; 2013 Dec; 18(23-24):1133-7. PubMed ID: 23892183
[TBL] [Abstract][Full Text] [Related]
2. Research and development productivity map: visualization of industry status.
Shimura H; Masuda S; Kimura H
J Clin Pharm Ther; 2014 Apr; 39(2):175-80. PubMed ID: 24438433
[TBL] [Abstract][Full Text] [Related]
3. Changing R&D models in research-based pharmaceutical companies.
Schuhmacher A; Gassmann O; Hinder M
J Transl Med; 2016 Apr; 14(1):105. PubMed ID: 27118048
[TBL] [Abstract][Full Text] [Related]
4. Accessing external innovation in drug discovery and development.
Tufféry P
Expert Opin Drug Discov; 2015 Jun; 10(6):579-89. PubMed ID: 25910932
[TBL] [Abstract][Full Text] [Related]
5. How should we support pharmaceutical innovation?
Grootendorst P
Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
[TBL] [Abstract][Full Text] [Related]
6. Mergers and innovation in the pharmaceutical industry.
Comanor WS; Scherer FM
J Health Econ; 2013 Jan; 32(1):106-13. PubMed ID: 23220457
[TBL] [Abstract][Full Text] [Related]
7. Racing to define pharmaceutical R&D external innovation models.
Wang L; Plump A; Ringel M
Drug Discov Today; 2015 Mar; 20(3):361-70. PubMed ID: 25448753
[TBL] [Abstract][Full Text] [Related]
8. Improving R&D productivity of pharmaceutical companies through public-private partnership: experiences from the Innovative Medicines Initiative.
Laverty H; Gunn M; Goldman M
Expert Rev Pharmacoecon Outcomes Res; 2012 Oct; 12(5):545-8. PubMed ID: 23136843
[No Abstract] [Full Text] [Related]
9. The development speed paradox: can increasing development speed reduce R&D productivity?
Lendrem DW; Lendrem BC
Drug Discov Today; 2014 Mar; 19(3):209-14. PubMed ID: 24051396
[TBL] [Abstract][Full Text] [Related]
10. How to revive breakthrough innovation in the pharmaceutical industry.
Munos BH; Chin WW
Sci Transl Med; 2011 Jun; 3(89):89cm16. PubMed ID: 21715677
[TBL] [Abstract][Full Text] [Related]
11. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
Federsel HJ
Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
[TBL] [Abstract][Full Text] [Related]
12. Virtual pharmaceutical companies: collaborating flexibly in pharmaceutical development.
Forster SP; Stegmaier J; Spycher R; Seeger S
Drug Discov Today; 2014 Mar; 19(3):348-55. PubMed ID: 24291787
[TBL] [Abstract][Full Text] [Related]
13. Brazil: An emerging partner in drug R&D.
Rodrigues DG
IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
[TBL] [Abstract][Full Text] [Related]
14. Current trends in the pharmaceutical industry--a case study approach.
Rusu A; Kuokkanen K; Heier A
Eur J Pharm Sci; 2011 Oct; 44(3):437-40. PubMed ID: 21782941
[TBL] [Abstract][Full Text] [Related]
15. Reviving an R&D pipeline: a step change in the Phase II success rate.
Wu SS; Fernando K; Allerton C; Jansen KU; Vincent MS; Dolsten M
Drug Discov Today; 2021 Feb; 26(2):308-314. PubMed ID: 33129994
[TBL] [Abstract][Full Text] [Related]
16. Value networks identify innovation in 21st century pharmaceutical research.
Edwards PJ
Drug Discov Today; 2009 Jan; 14(1-2):68-77. PubMed ID: 18973823
[TBL] [Abstract][Full Text] [Related]
17. Leveraging Industry-Academia Collaborations in Adaptive Biomedical Innovation.
Stewart SR; Barone PW; Bellisario A; Cooney CL; Sharp PA; Sinskey AJ; Natesan S; Springs SL
Clin Pharmacol Ther; 2016 Dec; 100(6):647-653. PubMed ID: 27617845
[TBL] [Abstract][Full Text] [Related]
18. The paradox of scientific excellence and the search for productivity in pharmaceutical research and development.
Grasela TH; Slusser R
Clin Pharmacol Ther; 2014 May; 95(5):521-7. PubMed ID: 24458012
[TBL] [Abstract][Full Text] [Related]
19. A decade of innovation in pharmaceutical R&D: the Chorus model.
Owens PK; Raddad E; Miller JW; Stille JR; Olovich KG; Smith NV; Jones RS; Scherer JC
Nat Rev Drug Discov; 2015 Jan; 14(1):17-28. PubMed ID: 25503514
[TBL] [Abstract][Full Text] [Related]
20. The case for entrepreneurship in R&D in the pharmaceutical industry.
Douglas FL; Narayanan VK; Mitchell L; Litan RE
Nat Rev Drug Discov; 2010 Sep; 9(9):683-9. PubMed ID: 20725093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
